remove any doubts over mileage allocations letting drivers see exactly what their private motoring costs mileage count is available with three levels of functionality to suit the needs have any organization perhaps your business needs nothing more than a monthly summary of business and private manages the mileage count plus service will give you that together with more accurate mpgreporting that has been available previously in the package that is simplicity itself and dramatically reduces your paperwork burden whole new world of automated fleet management is yours though when you choose mileage count premium see the detail love any journey including the reason for it with postcodes for actual start and finish points verified by Google Maps to ensure accuracy create automatic driver and vehicle event alerts calculate payments using actual 642-813 HMRC or your own company rates and to my knowledge information wherever you are using the Internet or a mobile phone integrate everything with your fuel card data including any other refueling and enjoy detailed mpg reporting flee 642-813 t-wide with mileage count premium offering system security assured through two-stage authorize Asian could you want any more well maybe you might find it useful to access a range of useful data for every vehicle in the fleet from watt to engine number without ever having to input the data he might want to automate service maintenance and repairs across the fleet to a system which offers vehicle technical data
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...